-
2006
Company Description
iVeena develops ocular drug products that eliminate the need for eye drop application and painful injections.
iVeena has five products in late pre-clinical and research phase. Targeted indications include Post Surgery Cataract Inflammation, Macular Degeneration (Wet AMD), Diabetic Retinopathy and Glaucoma.
-
Manufacturer:
Science and Engineering -
Formed:
2006 -
Company Website:
-
Company E-mail:
-
Company Address:
525 East 100 South, Suite 275Salt Lake City, UTUnited States -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits